HCC Pharm ApS: Financial statements 2023
CVR: 41029013
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HCC Pharm ApS (CVR 41029013) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 28,329 and a net result of DKK -4,274 compared with DKK -13,489 the year before. That is a decrease of 2.4% compared with the year before. Equity in the 2023 report amounted to DKK -90,088. The company had 1 employee in the financial year.
- Gross Profit
- DKK 28,329
- Profit/Loss
- DKK -4,274
- Equity
- DKK -90,088
- Total Assets
- DKK 550,128
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 28K | -4K | -90K | 1 |
| 2022 | - | 29K | -13K | -86K | 1 |
| 2021 | - | 18K | -25K | -72K | 1 |
| 2020 | - | -63K | -88K | -48K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HCC Pharm ApS has published its annual report for 2022. Gross profit came to DKK 29,016, and the net result was DKK -13,489.
About HCC Pharm ApS
HCC Pharm ApS is a Danish company of the type Anpartsselskab based in Haarby, founded in 2019. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Hartmuth Hermann Walter Kleiß. The company is owned by Hartmuth Hermann Walter Kleiß. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 21,630 and a net result of DKK -19,646 compared with DKK 21,488 the year before. Equity in the 2025 report amounted to DKK -88,244.